FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204451626> ?p ?o ?g. }

• W3204451626 abstract "Abstract BackgroundDrug-resistant tuberculosis continues to be a public health threat around the globe especially in developing countries. In 2018, the number of new cases of rifampicin-resistant tuberculosis was half a million and about 78% of them had multi-drug resistant tuberculosis. In Ethiopia, the overall proportion of multi-drug resistant tuberculosis was 11.6%. The latest treatment outcome data for people with multi-drug resistant tuberculosis show a global treatment success rate of 56%. Therefore, this study was aimed at assessing multi-drug resistant tuberculosis treatment outcomes and associated factors at St. Peter Specialized Hospital, Ethiopia, 2019. MethodsA retrospective cross-sectional study was done. A total of 384 patient medical charts selected by simple random sampling method were reviewed. The data was collected using a checklist from the patients’ medical charts. The collected data were analyzed with SPSS version 23 computer software package. Summary statistics of a given data for each variable were calculated. A logistic regression model was used to measure the association between the outcome and the predictor variable. Statistical significance was declared at p-value<0.05. Direction and strength of association were expressed using OR and 95% CI. ResultFrom a total of 384 patients, the majority of 245(63.8%) of the study subjects were females. The rate of poor treatment outcome was 173(45.1%). Male patients and patients in the age category of 39-60 years were less likely to have poor treatment outcome compared to female patients and patients in the age category of 18-38 years (AOR = 0.43, 95%CI (0.19, 0.10) and (AOR = 0.28, 95%CI (0.15, 0.52) respectively. Patients with a history of second-line TB drug resistance are more likely to have poor treatment outcomes (AOR = 3.81, 95%CI (1.84, 7.91). Poor treatment outcome was higher among patients with longer treatment duration (AOR = 3.23, 95%CI (1.82, 5.74) compared to patients with short treatment duration. ConclusionThe proportion of poor treatment outcome in patients with multi-drug resistant tuberculosis was high. Therefore, a concerted effort should be done at all levels to improve the treatment outcome of the MDR-TB." @default.
• W3204451626 created "2021-10-11" @default.
• W3204451626 creator A5039736672 @default.
• W3204451626 creator A5052635190 @default.
• W3204451626 creator A5080707128 @default.
• W3204451626 date "2020-09-29" @default.
• W3204451626 modified "2023-09-23" @default.
• W3204451626 title "Multi-Drug Resistant Tuberculosis Treatment Outcome and Associated Factors in Addis Ababa, Ethiopia: A Retrospective Cross-Sectional Study" @default.
• W3204451626 doi "https://doi.org/10.21203/rs.3.rs-83241/v1" @default.
• W3204451626 hasPublicationYear "2020" @default.
• W3204451626 type Work @default.
• W3204451626 sameAs 3204451626 @default.
• W3204451626 citedByCount "1" @default.
• W3204451626 countsByYear W32044516262022 @default.
• W3204451626 crossrefType "posted-content" @default.
• W3204451626 hasAuthorship W3204451626A5039736672 @default.
• W3204451626 hasAuthorship W3204451626A5052635190 @default.
• W3204451626 hasAuthorship W3204451626A5080707128 @default.
• W3204451626 hasBestOaLocation W32044516261 @default.
• W3204451626 hasConcept C126322002 @default.
• W3204451626 hasConcept C142052008 @default.
• W3204451626 hasConcept C142724271 @default.
• W3204451626 hasConcept C144024400 @default.
• W3204451626 hasConcept C149923435 @default.
• W3204451626 hasConcept C151956035 @default.
• W3204451626 hasConcept C15744967 @default.
• W3204451626 hasConcept C167135981 @default.
• W3204451626 hasConcept C180747234 @default.
• W3204451626 hasConcept C2777975735 @default.
• W3204451626 hasConcept C2778607973 @default.
• W3204451626 hasConcept C2779356329 @default.
• W3204451626 hasConcept C2781069245 @default.
• W3204451626 hasConcept C3020294253 @default.
• W3204451626 hasConcept C65409693 @default.
• W3204451626 hasConcept C71924100 @default.
• W3204451626 hasConceptScore W3204451626C126322002 @default.
• W3204451626 hasConceptScore W3204451626C142052008 @default.
• W3204451626 hasConceptScore W3204451626C142724271 @default.
• W3204451626 hasConceptScore W3204451626C144024400 @default.
• W3204451626 hasConceptScore W3204451626C149923435 @default.
• W3204451626 hasConceptScore W3204451626C151956035 @default.
• W3204451626 hasConceptScore W3204451626C15744967 @default.
• W3204451626 hasConceptScore W3204451626C167135981 @default.
• W3204451626 hasConceptScore W3204451626C180747234 @default.
• W3204451626 hasConceptScore W3204451626C2777975735 @default.
• W3204451626 hasConceptScore W3204451626C2778607973 @default.
• W3204451626 hasConceptScore W3204451626C2779356329 @default.
• W3204451626 hasConceptScore W3204451626C2781069245 @default.
• W3204451626 hasConceptScore W3204451626C3020294253 @default.
• W3204451626 hasConceptScore W3204451626C65409693 @default.
• W3204451626 hasConceptScore W3204451626C71924100 @default.
• W3204451626 hasLocation W32044516261 @default.
• W3204451626 hasOpenAccess W3204451626 @default.
• W3204451626 hasPrimaryLocation W32044516261 @default.
• W3204451626 hasRelatedWork W2077995131 @default.
• W3204451626 hasRelatedWork W2092367513 @default.
• W3204451626 hasRelatedWork W2277252832 @default.
• W3204451626 hasRelatedWork W2612960289 @default.
• W3204451626 hasRelatedWork W2903913877 @default.
• W3204451626 hasRelatedWork W3005615226 @default.
• W3204451626 hasRelatedWork W3208554283 @default.
• W3204451626 hasRelatedWork W4241470424 @default.
• W3204451626 hasRelatedWork W4313441172 @default.
• W3204451626 hasRelatedWork W4323341229 @default.
• W3204451626 isParatext "false" @default.
• W3204451626 isRetracted "false" @default.
• W3204451626 magId "3204451626" @default.
• W3204451626 workType "article" @default.